Page last updated: 2024-10-21

vanilmandelic acid and Central Nervous System Diseases

vanilmandelic acid has been researched along with Central Nervous System Diseases in 2 studies

Vanilmandelic Acid: A 3-O-methyl ether of 3,4-dihydroxymandelic acid. It is an end-stage metabolite of CATECHOLAMINES; EPINEPHRINE; and NOREPINEPHRINE.
vanillylmandelic acid : An aromatic ether that is the 3-O-methyl ether of 3,4-dihydroxymandelic acid.

Central Nervous System Diseases: Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yang, XF1
Lee, BL1
New, AL1
Ong, HY1
Ma, L1
Zhang, Q1
Ong, CN1
Oganov, RG1

Reviews

1 review available for vanilmandelic acid and Central Nervous System Diseases

ArticleYear
[The role of catecholamines in the pathogenesis of ischemic heart disease].
    Kardiologiia, 1969, Volume: 9, Issue:7

    Topics: Adrenal Glands; Animals; Blood Coagulation; Catecholamines; Central Nervous System Diseases; Coronar

1969

Other Studies

1 other study available for vanilmandelic acid and Central Nervous System Diseases

ArticleYear
Urinary homovanillic acid and vanillylmandelic acid in workers exposed to carbon disulfide.
    American journal of industrial medicine, 1996, Volume: 29, Issue:3

    Topics: Adult; Analysis of Variance; Carbon Disulfide; Central Nervous System Diseases; Chemical Industry; C

1996